Podcasts about mmr

What if someone living at the center of pop culture and public scrutiny was quietly fighting the same toxic health battles you are, and nobody talked about it?Jenny McCarthy joins KB for a raw, unfiltered conversation about autoimmune disease, mold toxicity, vaccine injury, and the clean beauty lies hiding in your makeup bag. After battling mycotoxin poisoning, celiac disease, Hashimoto's, leaky gut, candida, and MCAS, Jenny became one of the most outspoken advocates for individualized medicine and non-toxic living, and she holds nothing back.She also opens up about her son Evan: the seizure, the cardiac arrest, the autism diagnosis following the MMR vaccine, and how healing his gut through functional medicine stopped his life-threatening seizures and changed everything she believed about health advocacy.You'll discover:The raw truth about mycotoxin and mold poisoningThe peptide stack Jenny is currently using, and why sourcing mattersWhy she created Formless BeautyWhat self-love actually looks like in practice Two non-negotiable toxic-free habits anyone can start todayThis is a masterclass in feminine resilience, radical self-advocacy, and what it truly means to live non-toxic, from the inside out. Jenny hasn't just talked about clean living. She has lived through the darkest version of what happens when your body is overwhelmed by toxins, and she came back fighting.If this episode moved you, share it with someone who needs to hear it, and subscribe so you never miss an episode!

Don't get your goiters in a twist.....the next episode is here! Last time, we talked about measles, the first M of MMR. But mumps and rubella are so often overlooked! Join us this episode as we discuss these two diseases through the lens of media. We will talk about Brooklyn 99, Miss Marple, and so much in between! Join us as we learn a bit more about the impact that these diseases have had on not just our health, but our viewing habits. 

Specialized acaba de presentar su nueva gravel race, la Crux 5, que se lanza a la carrera aerodinámica adoptando las formas y la tija de sillín de la Tarmac pero con un paso de rueda de hasta 55 mm. Además, estrena el nuevo cockpit integrado Roval Terra un 78% más absorbente y perfiles de rueda aero. Y no es lo único que ha presentado Specialized esta semana, ya que también ha introducido el nuevo casco aero Evade 4. La nueva Crux 5 la vamos a ver en acción este fin de semana en la UNBOUND Gravel, donde SCOTT ha mandado al vigente ganador de la prueba con un prototipo RC Gravel con ruedas de 32”. Un prototipo con un aspecto bastante acabado, por cierto. Igual que el prototipo ¿de la nueva Oiz? que vimos en Nove Mesto en las manos de Simon Andreassen, del Orbea Factory Team, aunque rodó con la bici en modo prototipo con los logos del OOLAB. En el apartado semanal de nuestro “salseo” con la UCI nos hacemos eco de la pequeña victoria lograda por SRAM en el caso de la limitación de los desarrollos para competición. La UCI ha perdido la apelación sobre esta restricción y por ahora se ha cerrado la causa legal abierta el mes de septiembre pasado, cuando SRAM presentó una denuncia ante la Autoridad Belga de Competencia (BCA), en contra del protocolo de la UCI para limitar los desarrollos máximos. Pero las novedades no se han detenido ahí, Mondraker ha presentado la Anark, una bici para bike park y freeride inspirada en modelos míticos como la Foxy de enduro y la Summun de DH. MMR, por su parte, ha presentado la Aelion SLR, un montaje muy especial sobre la base de la Aelion SL, presentada hace un par de meses, con ruedas y componentes ENVE y CeramicSpeed en la transmisión. EVOC, por su parte, ha anunciado una nuevas tallas y colores para su Torso Protector. Este episodio ha sido posible gracias a Focus y su campaña “Beyond Numbers”, una campaña que nos habla de que una bici no sólo son los números que aparecen en la ficha técnica, sino también en cómo se siente cuando ruedas con ella, cómo tracciona, cómo entra en curva, cómo responde en el sendero... Tienes más detalles y un interesante vídeo, además del calendario de Test de sus Demo Days en https://www.focus-bikes.com/es_es/ Enlaces de interés: Nueva Specialized Crux 5: https://www.maillotmag.com/actualidad/nueva-specialized-crux-5-una-tarmac-para-gravel-race Scott RC Gravel 32'' en Unbound: https://www.maillotmag.com/actualidad/scott-pondra-en-liza-una-rc-gravel-con-ruedas-de-32-en-la-unbound-los-detalles Nueva Oiz a la vista: https://www.mtbpro.es/actualidad/nueva-orbea-oiz-la-vista-cazado-un-prototipo-de-orbea-en-nove-mesto Victoria de SRAM frente a la UCI: https://www.maillotmag.com/actualidad/victoria-para-sram-la-uci-pierde-la-apelacion-sobre-la-restriccion-de-desarrollos Mondraker Anark: https://www.mtbpro.es/actualidad/nueva-mondraker-anark-el-arma-definitiva-de-la-marca-para-bike-park-y-freeride MMR Aelion SLR: https://www.maillotmag.com/actualidad/mmr-eleva-el-nivel-con-la-aelion-slr-montada-con-enve-y-ceramicspeed Nuevo S-Works Evade 4: https://www.maillotmag.com/actualidad/nuevo-s-works-evade-4-mas-ventilacion-y-comodidad-con-la-misma-aerodinamica Evoc Torso Protector: https://www.mtbpro.es/actualidad/evoc-renueva-su-torso-protector-ahora-en-blanco-y-talla-xs

Send us Fan Mail On this episode, we dive back into the wild world of college sports with the NCAA's lead outside counsel, Rakesh Kilaru. Over the last year, NIL deals totaling over $240 million have been cleared by the College Sports Commission, in addition to the hundreds of millions of dollars that have been shared directly with college athletes by the schools. But we are in the midst of a battle over NIL enforcement centered on whether there should be any limits on how MMR partners, like Playfly and Learfield, pay athletes and whether the new revenue sharing cap will actually hold. We also get into eligibility lawsuits and why the Sports Broadcasting Act may not be the easy money fix some think it is. Thank you for listening! For the latest in sports law news and analysis, you can follow Gabe Feldman on twitter @sportslawguy .  

“Vaccine hesitancy in the U.S. should be understood as religious expression — not as the product of scientific misinformation. These debates have been proxies for existential concerns about justice and morality.” — Kira Ganga Kieffer Are anti-vaxxers simply bizarre anti-science crazies egged on by conspiracists like RFK Jr? For Kira Ganga Kieffer, author of Unvaccinated Under God, what she calls “vaccine hesitancy” in America is actually a more complicated and prescient affair. The prevailing narrative — that vaccine-hesitant people lack scientific facts or serve their own individual agendas — misunderstands what's actually happening. Kieffer's argument is that vaccine hesitancy is best understood as a kind of religiosity. Not in the narrow context of church doctrine, but in the broader sense of meaning-making, moral reasoning, and an intensely individualist relationship with the body that is deeply rooted in American evangelical and alternative-spiritual tradition. This hesitancy, Kieffer shows, is not new. It has been present since the smallpox vaccine in the eighteenth century. What recurs across very different eras and very different communities is a set of metaphysical rather than scientific concerns expressed in the language of wellness, purity, and bodily sovereignty. The most interesting political implication of Kieffer's argument is that the same hyperindividualistic anti-modern instinct behind vaccine hesitancy also drives the wellness movement, the rejection of AI, and the political coalition that coalesced around RFK Jr. She sees this as a broad and growing constituency that neither party has fully understood nor spoken to. Rather than crazies, today's anti-vaxxers might offer a window onto tomorrow's American politics. Five Takeaways •       Vaccine Hesitancy Is Moral Meaning-Making, Not Ignorance: The dominant public health framing: vaccine-hesitant people lack scientific knowledge. Kieffer's reframe: they are engaged in profound moral reasoning about the body, purity, parental responsibility, and the relationship between the individual and the state. The parent who fears the MMR vaccine is not asking a scientific question. They are asking: if I consent to this intervention and my child is harmed, am I responsible? That is a theological question — about guilt, intention, and moral agency — dressed in the language of health. •       Evangelical Hyperindividualism Is the Root: Kieffer's structural argument: American evangelical Christianity is, at its core, an individualist proposition. You are saved by your personal choices. This translates directly into the wellness culture's logic of bodily salvation: you are saved from illness, aging, and death by your personal choices about diet, supplements, and vaccines. The individual body becomes the site of spiritual as well as physical salvation. This hyperindividualism is very American — and very old. It predates the wellness movement and will outlast it. •       Vaccine Hesitancy Has Been Present Since the Eighteenth Century: Kieffer's most important historical corrective: vaccine hesitancy did not begin with COVID, with MMR, or with the anti-vaccine movement of the 1990s. It has been present since the smallpox inoculations of colonial Massachusetts. What recurs across very different eras is not the same people or the same science — it's the same core concerns: bodily purity, parental moral responsibility, and distrust of external authority over the body. Each generation clothes these concerns in the available language. Today it is wellness. Earlier it was religious freedom. •       RFK Jr.: Evangelical Crusader or Wellness Influencer? RFK Jr. shares many characteristics of the evangelical crusader — a sense of special mission, a narrative of persecution, a world divided into the awakened and the deceived. But Kieffer is careful not to put words in his mouth. What she observes: in his crusade for wellness and his critique of organised medicine, he channels the same instincts she traces throughout the book. His coalition is now showing signs of disillusionment — followers who believed he was a true believer are finding that political power complicates purity. They are looking for someone else. •       The Anti-Modern Instinct Will Shape American Politics: The same hyperindividualist, anti-modern instinct that drives vaccine hesitancy also drives the rejection of AI, the wellness movement's critique of pharmaceutical medicine, and the political formations that coalesced around RFK Jr. Kieffer sees a broad and growing constituency that packages distrust of modernity in spiritual terms: what is essentially good is nature, humanity, the unmediated body. Neither party has fully understood or spoken to this constituency. As skepticism about AI and hypertechnology grows, Kieffer expects it to become more politically significant, not less. About the Guest Kira Ganga Kieffer is a scholar of American religions, history, culture, and politics. She holds a PhD in Religious Studies from Boston University and is Visiting Assistant Professor of Religious Studies at Fairfield University. She is the author of Unvaccinated Under God: Religion and Vaccine Hesitancy in Modern America (Princeton University Press, May 19, 2026). She lives in Westport, Connecticut. References: •       Unvaccinated Under God: Religion and Vaccine Hesitancy in Modern America by Kira Ganga Kieffer (Princeton University Press, May 19, 2026). •       Matthew Avery Sutton, Chosen Land: How Christianity Made America and Americans Remade Christianity — referenced in the opening; the preceding KOA episode on American religion. •       Episode 2913: David Ost on Red Pill Politics — the companion episode on the anti-modern political impulse that Kieffer's book helps explain. About Keen On America Nobody asks more awkward questions than the Anglo-American writer and filmmaker Andrew Keen. In Keen On America, Andrew brings his pointed Transatlantic wit to making sense of the United States — hosting daily interviews about the history and future of this now venerable Republic. With nearly 2,900 episodes since the show launched on TechCrunch in 2010, Keen On America is the most prolific intellectual interview show in the history of podcasting. WebsiteSubstackYouTubeApple PodcastsSpotify

Send us Fan MailIn this episode of The Oncology Journal Club, the team cover one of the most talked-about pancreatic cancer papers of the year, unpacking the promising early results for daraxonrasib in previously treated RAS-mutated pancreatic cancer and the science behind new RAS(ON) therapeutics. The team also discuss a fascinating phase II study of single-cycle neoadjuvant pembrolizumab in MMR-deficient colon cancer, new recommendations from the Prostate Cancer Working Group 4 and why the terminology we use in prostate cancer matters.Along the way, there's discussion of Bob Marley's acral melanoma, multidisciplinary lung cancer meetings, androgen receptor-positive TNBC, HER2-mutant lung cancer and whether oxybutynin could help men experiencing androgen deprivation-related hot flushes.The Oncology Journal Club Podcast is hosted by Professor Craig Underhill, Dr Kate Clarke and Professor Chris Jackson, and proudly produced by The Oncology NetworkVisit oncologynetwork.com.au for Show Notes, to send us Voice Notes and more information. 

There have been several reported measles outbreaks within the US with increasing frequency over the last decade. Recent changes to the CDC/ACIP further add to concern regarding the MMR vaccine and potential future illnesses. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In 1998, a British doctor, Andrew Wakefield, published a paper in the medical journal The Lancet that suggested a possible link between the MMR vaccine and the development of autism, alongside bowel problems. He pointed to what he said was a pattern: children developing normally, receiving the vaccine, and then experiencing a loss of skills. The paper was later retracted. Wakefield was denounced as a fraud and he was struck off the medical register. Now, nearly 30 years later, the mother of one of the children in Wakefield's study has decided to speak out. Paula Aitken's son Colin was known as Child Number Four. In a bombshell interview Paula tells Richie why she believes her son's autism was triggered by antibiotics, not just vaccines and that Andrew Wakefield's study was in fact a front for a sinister agenda, an agenda so dangerous that people have been murdered to ensure it never comes to light. Do NOT miss this show. 

On America at Night with McGraw Milhaven, Heather Simpson, co-founder of Back to the Vax, joined the program to discuss the ongoing debate surrounding childhood vaccinations. The conversation focused on how recent measles outbreaks are prompting some parents who once aligned with the MAHA movement to reconsider and return to the MMR vaccine. Next, Dr. Sal Mercogliano, Chair of the Department of History, Criminal Justice, and Political Science at Campbell University and host of the popular YouTube channel “What's Going On With Shipping,” explained the concept of naval blockades and why tensions in the Strait of Hormuz can have such a significant impact on global trade, oil markets, and prices felt by consumers at home. Then Sven Beckert, Laird Bell Professor of History at Harvard University, joined the show to discuss capitalism, its historical development, and how global economic systems continue to shape modern society and political debate. Finally, Bill Clevlen, founder of billontheroad.com, returned for the weekly travel segment, sharing stories and travel insights from destinations across the country. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Welcome back to The Dive Driven by Kia! To begin, Meteos gives listeners a behind-the-scenes peek inside the QA team and the play testing they've done on the announced Season 2 changes. Alternate builds, more versatility and creativity, item adjustments- looks like we're gearing up for an exciting next step in Demacia!Next up: one of the hottest topics for high ELO-players: rank and MMR reset. With every reset comes the age-old debate… shorter queue times or perfect matchmaking? You can't have both, so which would you choose?Our hosts also recapped LCS Spring Week 3, where C9 and TLAW have solidified themselves as undefeated leaders. Sentinels, on the other hand, picked up their first win. Could this be the momentum they need to push toward playoffs? Teams like DSG, DIG, and FLY still have more to show, this stage is far from over! After breaking down last week's matches, Azael, Kobe, and Meteos shared their predictions heading into Week 4.DON'T FORGET! LCS Spring Finals tickets are on sale for all viewers! Claim your spot at ASU's Mullett Arena to see which team will lift the trophy- we'll see you there! https://lolesports.com/en-US/news/lcs-spring-finals-heads-to-asu-at-mullett-arenaTimestamps:0:00 - Intro & Kobe's lucky number1:50 - Meteos' Season 2 Thoughts!17:30 - Rank Reset for Apex Players27:46 - Short Queue Times or Perfect Matchmaking?32:42 - Spring Finals Tickets are Live!33:44 - C9 vs DSG Recap48:33 - FLY vs SEN Recap59:44 - SR vs LYON Recap1:08:36 - TLAW vs DIG Recap1:16:05 - Week 4 Lookahead!

(Apr 23, 2026) MMR vaccine rates in St. Lawrence County lag behind the statewide average; we head to Lake George, where a parking meter enforcer says he's trying to be a "helpful busybody;" and North Country PBS stations and libraries are hosting screenings of a documentary about the national fight against book bans on Thursday.

Earlier this year, the UK lost its status as a measles-free country after a rise in deaths from the disease and a fall in the proportion of children having the MMR jab. Yesterday, the House of Lords Childhood Vaccinations Rates in England Inquiry questioned witnesses from a range of healthcare settings, including GPs and practice nurses, health visitors and midwifery experts to find out exactly what is happening and why vaccination rates are falling. Presenter Nuala McGovern is joined by the Chair of that inquiry, Baroness Joan Walmsley. Women make up 75% of those who have used the Couch to 5k app, which turns 10 years old today. Over the past decade, the running companion has been downloaded more than eight million times and inspired an incredible one billion minutes of movement. Nuala is joined by Jo Whiley, the most popular coach on the app, and Claire Baird and Ellen Morris, who have completed the challenge. Earlier this month, in a landmark verdict in the Scottish courts, Lee Milne was found guilty of culpable homicide after his wife Kimberly took her own life. Culpable homicide is similar to the charge of manslaughter in England and Wales. His coercive and controlling behaviour was said to have been a significant contributing factor in Kimberly's death. Laura Buchan, Legal Director with the Crown Office and Procurator Fiscal Service and Kate Ellis, Joint Head of the Litigation Team at the Centre for Women's Justice, join Nuala to discuss. On what would have been Queen Elizabeth II's 100th birthday, we explore her enduring legacy, the new monuments that will commemorate her reign, and how future generations may remember her. We hear from Tessa Dunlop, author of Lest We Forget: War and Peace in 100 British Monuments, and BBC Royal Correspondent Daniela Relph. Presenter: Nuala McGovern Producer: Sarah Jane Griffiths

In this episode of the Contagion Podcast, we take on one of the most pressing challenges in modern medicine: vaccine hesitancy. As misinformation spreads rapidly across social media and trust in institutions continues to shift, clinicians are increasingly navigating complex, emotionally charged conversations with patients and families.To explore this issue, we sit down with Dr. Lisa Hayes, a board-certified pediatrician, to better understand what vaccine hesitancy looks like today—from inside the exam room. From routine well-child visits to high-stakes discussions about safety and risk, Dr. Hayes shares her firsthand experience engaging with parents who are uncertain, skeptical, or simply overwhelmed by the volume of information coming at them from every direction.We begin by examining how we got here. Vaccine hesitancy is not new, but it has evolved dramatically over time. From early debates around smallpox vaccination to the lasting impact of the now-debunked MMR-autism claims, historical events have shaped public perception in lasting ways. Layer onto that the rise of digital media, where health information—and misinformation—spreads faster than ever, and the COVID-19 pandemic, which further strained trust and amplified division.  But this episode goes beyond history. We focus on the real-world dynamics of these conversations today. What are parents most concerned about? How do clinicians decide when to lead with data, when to lead with empathy, and how to balance both? And what happens when deeply held beliefs collide with public health recommendations?We also take an honest look at the broader context of mistrust in healthcare, particularly among communities that have experienced bias, dismissal, or inequity. Understanding this backdrop is essential to rebuilding meaningful connections with patients.Finally, we turn toward solutions. What strategies actually work? How can clinicians meet families where they are without compromising scientific integrity? And what does the future of vaccine communication look like in an era defined by information overload?This is a conversation about more than vaccines—it's about trust, communication, and the evolving role of the clinician in a rapidly changing world.Dr. Vega would like to thank her friend Job Meiller for his musical contributions, "For what it's worth," and "Hey, soul sister," to our major segment breaks. Thank you, Job!Thanks also to Dr. Ana Velez, our artistic contributor, for her artwork utilized in our episode thumbnail, "Motherhood in a darkened world."

Recapping what I learned at HOPA 2026: -Beyond steroids for irAs -IT chemo beyond methotrexate and cytarabine -Pre-emptive CMV management in patients receiving certain bispecifics -semaglutide-alectinib drug interaction -Safety (n = ~40) of MMR vaccine in patients post-Auto transplant on maintenance daratumumab Check out the Oncology Insights Newsletter: www.kelleycpharmd.com/newsletter-oncopharm

In this powerful episode, Dr. Tony Ebel sits down with Dr. Brian Hooker, PhD — Senior Director of Science and Research at Children's Health Defense and co-author of the New York Times bestselling book Vax-Unvax: Let the Science Speak. Brian shares his personal journey as a father whose son regressed into autism following his 15-month vaccines, and how that experience drove over 20 years of research and advocacy. Together, they connect the dots between C-section birth, recurrent ear infections, acetaminophen, and vaccine injury — the full picture of the "perfect storm." Brian also recounts his relationship with CDC whistleblower Dr. William Thompson, the suppressed MMR data, the dangers of glyphosate and acetaminophen, and what Children's Health Defense is focused on to both heal kids already in the storm and prevent the next generation from entering it.-----Links & Resources:website: https://childrenshealthdefense.org/book: Vax-Unvax: Let the Science Speak (available on Amazon)-----Key Topics & Timestamps07:00 Brian's Personal Story: His Son's Birth, Early Development, and the Perfect Storm09:00 The 15-Month Well-Baby Visit: Vaccines, Ear Infection, and the Regression into Autism13:00 C-Section Deep Dive: Birth Trauma, the Brainstem, and the Neurological Connection20:00 Finding an Integrative Pediatrician and the First Hair Metals Test22:00 The CDC Calls and Dr. William Thompson: From Dismissal to Whistleblower25:00 What the Suppressed MMR Data Actually Showed29:00 The Origin of Vax-Unvax and the 100 Studies That Changed Everything34:00 Vaccinated vs. Unvaccinated: What the Science Says About Children's Health42:00 Beyond Vaccines: Glyphosate and Acetaminophen as Neuro-Immune Threats47:00 Healing Protocols, CHD's Mission, and Preventing the Next Generation's Perfect Storm-- Follow us on Socials: Instagram: @pxdocsFacebook: Dr. Tony Ebel & The PX Docs NetworkYoutube: The PX DocsFor more information, visit PXDocs.com to read informative articles about the power of Neurologically-Focused Chiropractic Care.Find a PX Doc Office near me: PX DOCS DirectoryTo watch Dr. Tony's 30 min Perfect Storm Webinar: Click Here

This episode we begin to explore the MMR vaccine and the diseases it protects against (Measles, Mumps, and Rubella). We focus mostly on measles, as there is a lot of ground to cover. Angel talks about its reign of terror, and the way it affected entire nations, as it spread across the world...or wait, was that just colonizers? As we discuss, they often came together! Maya discusses religious groups, and how extreme beliefs often come hand-in-hand with new measles outbreaks. Join us as we break down a classic viral disease, and come back for the next episode, where we talk about the other M and R, mumps and rubella in popular media! 

In this follow-up to our NIL compliance webinar, we take a closer look at where the new framework is starting to strain. From NIL Go reporting challenges to bundled deal structures and MMR involvement, we unpack the issues that may create the most confusion—and risk—for athletes and schools. It's a practical, issue-spotting conversation on what comes next.If you haven't seen the original NIL compliance webinar, or just want to revisit it, you can check it out here!

Should families be allowed to send their children to public school without their MMR vaccine due to religious, medical or other reasons? Chad opens the show with that topic along with data on how many Minnesota kids in schools are unvaccinated.

Chad opens the show talking about the growing number of Minnesota public school children getting exemptions from taking the MMR vaccine before our usual Tuesday Q&A with Adam Carter during Ask Adam Anything.

Adam Carter hangs around for the entire first hour today to talk about MMR vaccine numbers and exemptions for kids in Minnesota before Ask Adam Anything. Later, Minnesota radio legend and Chad's great friend Tom Barnard joins to talk about life after his Alzheimer's diagnosis and the immense hope he has with the treatment he's receiving. Plus, we talk with our financial guru Brian Belski about the economy, Jeff Day details the state's lawsuit against DOJ and DHS and much more!

Send Zorba a message!Zorba and Karl discuss why doctors are concerned that we're seeing a huge drop in official health alerts from the CDC. Zorba helps a caller with her pesky gardening rash. An emailer questions the affordability of eating according to the new dietary guidelines, and Zorba helps out a listener with hiccups. We hear a mom joke, and the CBD Cops make a visit. Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!

Send Zorba a message!Zorba and Karl discuss why doctors are concerned that we're seeing a huge drop in official health alerts from the CDC. Zorba helps a caller with her pesky gardening rash. An emailer questions the affordability of eating according to the new dietary guidelines, and Zorba helps out a listener with hiccups. We hear a mom joke, and the CBD Cops make a visit. Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!

Talking with Michelle Horsley, autistic researcher, artist, and writer of the Aut Naught Aut, mapping the parapolitical architecture of the autism industrial complex… From her personal experiences growing up autistic to her extensive research into the historical and current narratives surrounding autism.Her insights challenge mainstream as well as alternative perceptions and reveal layers of political and social complexities. She advocates for a more informed and empathetic understanding of autism that truly centers the voices of those within the community.On being five and nearly institutionalized, on cousins who disappeared into care and were never spoken of, on the mercy of small schools and open fields, on learning to speak through rote phrases like operating systems, on meaning blindness, on writing poetry to break the blocks, on internet relay chat in 1992 and the joy of text-only communion, on autistic people discovering each other online for the first time, on the flowering of recognition, on the anti-vax people arriving in autistic spaces and tearing it all down, on being told your identity is a disease, on Scientologists using communication tech as a weapon, on the split between autistic adults and parents of autistic children that became unbridgeable, on Leo Kanner, on childhood schizophrenia, on post-immunization encephalopathy, on Bernard Rimland wearing two hats — hero to the parent community and career naval psychologist directing future technologies, on the 1958 National Defense Education Act and the state's interest in gifted minors, on gifted and talented programs, on MKUltra, on Kim Peek, on the military search for savants, on Scientology level OT VIII, on Operation Snow White, on RFK Jr., on Generation Rescue, on Bob Wright, on ARPA-H, on the after-party to TED Talks, on Andrew Wakefield's very small study that said nothing about the MMR, on overstimulation and the mind whiting out, on the map that is always provisional, on following the hacktivists. on the state being hostile to ordinary people, on questioning everything, on c self-expression, on being less autistic than she used to be, on identifying plants intuitively, on tending a vineyard and making wine and losing goats to wolves, on the techno-utopian dystopia not working, on the return to non-technological ways of living, on failure as liberation…ExcerptsOn Hyper Associational Autism we have hyper associational kind of minds, … so I do make links between things that seem unrelated… I've been building this map. And as the map comes together and informs, I can start to make predictions. And if it's accurate, then I know my map is pretty close to what's really going on.On Autism and ScientologistsThis battle between autistics and Scientologists has been going on for decades.Bernard Rimland completely took over the perception of what autism is. On one hand , in the autism parent community, he was Mr. Hero. But on the other side, he was a career naval psychologist, a research psychologist, director of future technologies and recruit enhancement.Scientologists don't just, they're very careful about who they associate with. So for a Scientologist to be an in-house lawyer at Children's Health Defense means that organization is affiliated with Scientology strongly.” “It's not even a cult. It's more what is it. You could say it's a cult that's that's operationalized in terms of it's intelligence work.On Vaccines and AutismVaccines don't cause autism, but vaccines are not good. In fact, vaccines probably are injuring children, but the two things got all mixed up together and he's (RFK JR) part of that. I just want to really encourage listeners to question, recognize that the Health Freedom movement is full of Scientologists and they're not your friends. Not everybody who's communicating with you is telling you the truth, especially, online.Aut Naught AutAspie Quizhttps://rdos.net/eng/Aspie-quiz.phpArtwork by Michelle Horsley Get full access to Leafbox at leafbox.substack.com/subscribe

00:00 and justice for all. 00:06 you 00:09 For spacious skies, for amber waves of grain, for purple mountain majesties. 00:40 God shed his grace on thee. 00:51 you 00:54 from sea to shining sea. America is back. Yes, sir. And we are back. And I got to tell you, folks, we've got less than three months until the primaries. Less than three months. Get ready. It's coming up on June 9th. 01:24 Oh my goodness, that's too quick. So a little while ago, there was a bill in front of the House and this was uh put forth by Marjorie Bright Matthews, a Democrat, and that would remove the religious exemptions from the MMR vaccine. Would have done away with the religious exemption. Now, this bill was sent 01:53 Well, it didn't move out of the subcommittee because there are watchdogs in Columbia, the people that are there actually keeping a close eye on our state legislature. And now the state legislature, they don't like that very much. They don't like the fact that they've got people looking over their shoulders. Joining us right now is Elena Moore with Palmetto State Watch. Elena, these people really don't like you watchdogs in Columbia, do they? eh 02:20 It appears that way. I knew that they didn't like us, but I didn't know that it was this intense. Yeah, they're going to have a bill to put a whole lot of restrictions on you folks, right? It's called uh S960. Tell us about it. Yes, S960 was filed the same day that that MMR vaccine bill was scheduled for a hearing, which should have never even made it to a hearing, let alone been heard being a uh 02:49 supposedly red state, but S 960 is the ultimate incumbent protection act as it eliminates all opposition to elected officials. This bill is how you completely control elections in South Carolina with discouraging citizens from participating. instead of the power of the people, the little bit of power that we do have, it will be shifted to only those that can afford the detailed compliance requirements. 03:14 that are funded by donors who would not be impacted like George Soros and Bill Gates. And I can go a little bit into what's actually in S960. Yeah, let's hear it. So S960, it defines election communication that would encompass any paid message supported or opposing a clearly identified candidate or ballot measure. So not even just a candidate, it can be just a ballot measure over TV, radio, internet or print. 03:39 And they pretty much would consider anything like that to be considered election communications. So pretty much anything political almost. The bill also redefined or defines independent expenditure committee as any one or any group that spends $500 or more on political messaging that will be classified as an independent expenditure committee. If you qualify as this, you now have to provide very detailed compliance rules, including major donor and spending disclosures. 04:09 And the main things that they would have you do is disclose your donors that have contributed $1,000 or more with their name, address, occupation, personal information. They would have you list your spending disclosures. So any vendors that you have, any fundraisers that you have, um you have to report any transfers to political committees or any debts and obligations. 04:34 The third thing you'd have to do is you'd have forced disclaimers on communication. So any communications that you have in the internet, on print or mail, you'd have to put your committee name. And then if you're on radio, TV, or even just doing a podcast, you'd have to say your committee name and also say the address with it as well. Good grief. It's crazy. mean, no one, and it gets even worse because the other two things that they would have you do, 05:03 is maintain your records for four years, and if that wasn't enough, you'd have to file with the State Ethics Commission on the same schedule as campaign reports. So basically, if you're trying to get involved in politics at all, you would be ...

In his weekly clinical update, Dr. Griffin and Vincent Racaniello talk about the health misconceptions that RFK Jr continues to perpetuate and how to combat them, first cases of highly pathogenic influenza in the California elephant seal population before Dr. Griffin deep dives into economic costs of not vaccinating against measles, the measles outbreak in South Carolinaand Utah, ICE detention centers, lack of accurate reporting may prevent the US from losing its status as a country that eliminated measles, immune amnesia from measles infection, influenza strain selection for the 2026-2027 vaccine,  recent statistics for RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, where to find PEMGARDA, how to access and pay for Paxlovid, when to use steroids for treating influenza, long COVID treatment center, where to go for answers to your long COVID questions, clinical trials for long COVID treatment including GLP-1 inhibitors and IVIG and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Kristen Panthagani, MD, PhD (Substack) You can know things! (Substack) Kmpanthagani: Kristen Panthagani, MD, PhD Instagram) Kristen Panthagani, MD, PhD kmpanthagani (Threads) Psychological inoculation improves resilience against misinformation on social media (Science) 5 Logical fallacies in the era of RFK Jr. (Substack) Tecovirimat for the Treatment of Mpox (NEJM) California records avian flu in northern elephant seals (CIDRAP) First Cases of Highly Pathogenic Avian Influenza in Northern Elephant Seals Confirmed in California (UC Davis) Wastewater for measles (WasterWater Scan) The health and economic repercussions of declining MMR coverage in the United States (medRxiv) 2025 measles resurgence carries estimated $244 million price tag (CIDRAP) US builds case to retain measles elimination status as infections mount (Reuters) Expert meeting on US measles elimination status delayed to November (Reuters) 'Nearly Every' Child With Measles Suffers This Hidden Threat (Medscape) CDC acting director Bhattacharya urges use of measles vaccine (Reuters) Measles cases and outbreaks (CDC Rubeola) Measles Dashboard (South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) Utah Measles Dashboard (Utah Department of Health and Human Services) Escobar: ICE sending sick migrants to El Paso hospitals for quarantine (BorderReport) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) Weekly surveillance report: cliff notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) RSV Detection and Antibiotic Prescribing Decisions for Pediatric Respiratory Tract Infections (JAMA Network) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID SARS-CoV-2Persistence and the Gut Microbiota: New Insights into Long COVID Pathogenesis (MDPI) Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19 (Annals of Internal Medicine) Long COVID: RECOVER-TLC Clinical Trials (Foundation for the National Institute of Health) Design and rationale of RECOVER-AUTONOMIC: A randomized platform trial evaluating interventions for Long COVID postural orthostatic tachycardia syndrome (American Heart Journal) Dr. Ruth's Newsletter: COVID, Flu & Health News, 3/1/26 (Substack) Reaching out to US house representative Letters read on TWiV 1302 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

00:00 And welcome to the program on your yay Friday afternoon. And what a Friday afternoon it is, ladies and gentlemen, we set a record high today. The old record was 79, some places throughout the Greenville area recorded 81 degrees. So it's 82 right now, so there you go. 00:24 82 degrees, that is a record. Oh, it's the global warming. Charlie, no, it's not hush. It's just not. got we got some more cool weather coming in the next few days. So don't you worry too much about that. OK, we have got a beaucoup things to talk about today. We really do. I want to start off with with this because something happened. 00:52 back on February the 5th. 00:57 Something kind of strange happened in our state house where we have a quote unquote Republican majority. You see, there was a bill filed on February the 5th by a Democrat state Senator Margie Bright Matthews. Now, that's not weird. Bills are filed in Columbia all the time. 01:26 Every single year, thousands of them, the vast majority of these bills go quietly into a committee where they remain until they die. But not this bill. Not this one. S897 and this is what the folks over at Palmetto State Watch S897 proposes to remove the religious exemptions for the measles, mumps and rubella. The MMR vaccine for children attending public institution and daycares. 01:55 as well as for young adults attending a university. This means any person enrolled in a public education and any child attending daycare or planning to attend college must get two doses of the MMR vaccine unless they have a medical exemption, which is extremely difficult to obtain. So somehow, S897 oh 02:24 managed to get on the schedule for a subcommittee hearing. 02:30 two days ago on Wednesday at 930 A.M. in the Gresset building in Columbia. This bill has no co-sponsors whatsoever and is sponsored by a Democrat. 02:46 in a Republican majority state. 02:50 Now, how does this even happen? 02:55 How does this, I mean, how does it even happen? 02:59 When we were supposed to be Ruby Red South, folks, let me tell you, every single day, our state legislature gives you another reason to get out and vote on June 9th in a big, huge way. We all remember COVID. We all remember the mandates. We all remember that you had to have the experimental jab. We all remember that. They act like we haven't forgotten. But because we had an outbreak, 03:29 of the measles in Spartanburg, now all of a sudden, we're gonna do away with the religious exemptions for the jab. Over the last few months, the folks at Palmetto State Watch heard that South Carolina is now the leader in the nations for the measles outbreak in the Spartanburg area since October of 2025. The numbers, they said, is now approaching 1,000 cases, and that's cumulative since October. 03:59 This is oddly reminiscent of another situation our country went through a few years back. Anybody remember COVID? Of course you do. What we're not hearing is how many people have recovered, what long-term complications they've had, how many have died, how many current cases are there. It's just an ever-increasing number that is intended to strike fear in everybody's soul. 04:24 I want you to listen to this. This is, I'm not sure who this is, this Dawn Richardson, Director of Advocacy for NVIC. So in South Carolina, there was a bill just dropped that would remove the religious exemption for just the MMR vaccine for kids in child care, kids in school, and then also it would mandate the MMR vaccine without exemptions for people in college. Now, 04:51 This was filed because in Spartanburg County there's been an outbreak. About 95 % of the cases have occurred in this one county. But what's interesting in that county, they did a huge vaccination push. They vaccinated over 1200 kids aged six months to 11 months. The important thing is they can spread it. And so the problem with going and putting all these vaccines out there, first of all, they're live virus. Second of all ...

HOUR 1 1st - We set a weather record today 81; 2nd - Zoran Mandani has problems in New York 3rd - We don't know who Trump is going to endorse in the TX senate race 4th - 00:00 And welcome to the program on your yay Friday afternoon and what a Friday afternoon it is ladies and gentlemen, we set a record high today. The old record was 79 some places throughout the Greenville area recorded 81 degrees. So it's 82 right now, so there you go. 00:24 82 degrees, that is a record. Oh, it's the global warming. Charlie, no, it's not hush. It's just not. got we got some more cool weather coming in the next few days. So don't you worry too much about that. OK, we have got a beaucoup things to talk about today. We really do. I want to start off with with this because something happened. 00:52 back on February the 5th. 00:57 Something kind of strange happened in our state house where we have a quote unquote Republican majority. You see, there was a bill filed on February the 5th by a Democrat state Senator Margie Bright Matthews. Now, that's not weird. Bills are filed in Columbia all the time. 01:26 Every single year, thousands of them. vast majority of these bills go quietly into a committee where they remain until they die. But not this bill. Not this one. S897 and this is what the folks over at Palmetto State Watch S897 proposes to remove the religious exemptions for the measles, mumps and rubella, the MMR vaccine for children attending public institution and daycares. 01:55 as well as for young adults attending a university. This means any person enrolled in a public education and any child attending daycare or planning to attend college must get two doses of the MMR vaccine unless they have a medical exemption, which is extremely difficult to obtain. So somehow, S897 02:24 managed to get on the schedule for a subcommittee hearing. 02:30 two days ago on Wednesday at 930 A.M. in the Gresset building in Columbia. This bill has no co-sponsors whatsoever and is sponsored by a Democrat. 02:46 in a Republican majority state. 02:50 Now, how does this even happen? 02:55 How does this, I mean, how does it even happen? 02:59 When we were supposed to be Ruby Red South, folks, let me tell you, every single day, our state legislature gives you another reason to get out and vote on June 9th in a big, huge way. We all remember COVID. We all remember the mandates. We all remember that you had to have the experimental jab. We all remember that. They act like we haven't forgotten. But because we had an outbreak, 03:29 of the measles in Spartanburg, now all of a sudden, we're gonna do away with the religious exemptions for the jab. Over the last few months, the folks at Palmetto State Watch heard that South Carolina is now the leader in the nations for the measles outbreak in the Spartanburg area since October of 2025. The numbers, they said, is now approaching 1,000 cases, and that's cumulative since October. 03:59 This is oddly reminiscent of another situation our country went through a few years back. Anybody remember COVID? Of course you do. What we're not hearing is how many people have recovered, what long-term complications they've had, how many have died, how many current cases are there. It's just an ever-increasing number that is intended to strike fear in everybody's soul. 04:24 I want you to listen to this. This is, I'm not sure who this is, this Dawn Richardson, Director of Advocacy for NVIC. So in South Carolina, there was a bill just dropped that would remove the religious exemption for just the MMR vaccine for kids in child care, kids in school, and then also it would mandate the MMR vaccine without exemptions for people in college. Now, 04:51 This was filed because in Spartanburg County there's been an outbreak. About 95 % of the cases have occurred in this one county. But what's interesting in that county, they did a huge vaccination push. They vaccinated over 1200 kids aged six months to 11 m ...

South Carolina parents are mobilizing as two conflicting vaccine bills hit the legislature. One would ban religious exemptions for the MMR vaccine, while another protects children under 24 months from mandates. Tara and Amanda Hovis break down the science, the politics, and the fight for parental rights.

Tara covers two explosive topics today: South Carolina's vaccine legislation threatening parental rights, and why President Trump's strike on Iran was legally and strategically justified. From MMR debates to AUMFs and imminent threats, this episode breaks down the facts the mainstream media won't cover.

This week's stories: Sinclair's This Is the Test: Are we about to see age reversal in humans? At the World Governments Summit 2026 in Dubai, Harvard geneticist David Sinclair told world leaders that ageing could soon be reversible and said the first human clinical trials of epigenetic reprogramming therapies are moving forward. The core idea is that ageing is partly an information problem, how cells read DNA, not just cumulative damage, and that partial reprogramming could restore youthful function without turning tissues into tumors. Dave frames this as a rare binary moment for longevity: either early, localized human trials (starting with tightly controlled tissue targets like the eye) show meaningful functional rejuvenation with acceptable safety, or the field has to recalibrate fast. Either way, the next couple of years will heavily influence where money, regulators, and serious researchers place their bets. • Sources: – World Governments Summit: https://www.worldgovernmentssummit.org/media-hub/news/detail/ageing-could-soon-be-reversible-says-harvard-scientist-at-wgs-2026 – NAD / Life Biosciences coverage: https://www.nad.com/news/fda-greenlights-life-biosciences-human-study-setting-up-pivotal-test-for-aging-theory-from-harvards-david-sinclair AlphaFold 4 in a locked box: DeepMind's private AI drug design engine Isomorphic Labs, DeepMind's drug discovery company, unveiled a proprietary drug design engine that outside scientists are comparing to an AlphaFold 4 moment, but for designing drugs, not just predicting structures. The big shift is that this system is closed: no public weights, no open database, and access appears to flow through partnerships with pharma companies. Dave breaks down why that matters for the longevity world: if AI makes early discovery cheaper and faster, we might see more serious shots on ageing targets over the next decade, but a closed model can also mean less transparency, bigger IP moats, and no guarantee that faster discovery leads to cheaper drugs. • Sources: – Nature: https://www.nature.com/articles/d41586-026-00365-7 – Isomorphic Labs: https://www.isomorphiclabs.com/articles/the-isomorphic-labs-drug-design-engine-unlocks-a-new-frontier Peptides in the freezer: El Mencho's anti aging stash and the dark side of wellness After reports and images from the final hideout linked to Jalisco New Generation Cartel leader Nemesio Oseguera Cervantes (El Mencho), coverage highlighted a detail that feels uncomfortably familiar to anyone in the modern wellness internet: injectable vials stored in a freezer with a schedule attached, including Tationil Plus, a glutathione based injectable marketed in some places for “cellular health,” cosmetic effects, and anti ageing. Dave uses the absurdity as a narrative wedge, not cartel gossip, to talk about how normalized gray market injectables have become, and how marketing (“detox,” “cellular reset”) often outruns evidence and safety. The segment pivots into a practical filter: which compounds are real therapeutics under medical supervision, and which are expensive folklore with sourcing risk and unknown long term downsides. • Sources: – New York Post: https://nypost.com/2026/02/25/world-news/inside-the-luxurious-love-nest-where-mexican-drug-lord-el-mencho-spent-his-final-days/ – Sky News (Reuters photos referenced): https://news.sky.com/story/inside-the-mexican-villa-where-feared-drug-lord-el-mencho-spent-final-hours-13511954 – Reuters photo gallery: https://www.reuters.com/pictures/el-menchos-last-hideout-inside-villa-where-cartel-leader-spent-final-hours-2026-02-25/W7DK5WEXS5IMLLZQO2P3CXGXFM The disease we thought was dead: measles comes roaring back Measles cases have surged in early 2026, with reporting citing at least 588 cases in the U.S. by late January, already more than many full year totals, and additional updates showing continued acceleration into February. Dave reframes this as a healthspan floor issue: you can argue about peptides and mitochondria all day, but measles is so contagious that once community immunity drops, outbreaks move fast and hit the most vulnerable first, especially infants and immunocompromised people. He also flags the systems problem: many clinicians have never seen measles, which increases the odds of delayed recognition and wider exposure in waiting rooms. The actionable move is boring and high ROI: verify MMR status for you and your family and close gaps before outbreaks get closer to home. • Sources: – AMA Morning Rounds (Week of Feb. 2, 2026): https://www.ama-assn.org/about/publications-newsletters/top-news-stories-ama-morning-rounds-week-feb-2-2026 – ABC News (CDC case count coverage): https://abcnews.com/Health/588-us-measles-cases-reported-january-cdc/story?id=129699078 – CIDRAP (case tracking context): https://www.cidrap.umn.edu/measles/us-measles-cases-soar-588-so-far-year-south-carolina-confirms-58-new-infections DC vs your health: Trump's State of the Union health reset President Donald Trump's 2026 State of the Union included a cluster of healthcare themes that function as a directional signal for agencies and payers this year, including drug pricing rhetoric, price transparency, and broader coverage and affordability framing. Dave translates the politics into a practical heuristic for biohackers: federal posture quietly determines what becomes easy versus painful to access in the legitimate system, from GLP 1 coverage rules and prior auth behavior to how friendly the environment is for telehealth, at home diagnostics, and eventually whatever “real longevity medicine” looks like. You do not need every policy detail in a weekly rundown, just the weather report: reimbursement and enforcement trends shape what stays niche, what scales, and what gets friction. • Sources: – Advisory Board: https://www.advisory.com/daily-briefing/2026/02/25/health-policy-roundup – Healthcare Dive: https://www.healthcaredive.com/news/trump-state-of-the-union-healthcare-2026/812962/ – This Week in Public Health analysis: https://thisweekinpublichealth.com/blog/2026/02/25/the-2026-state-of-the-union-what-it-means-for-health-and-public-health/ All source links are provided for direct access to the original reporting and research. This episode is designed for biohackers, longevity seekers, and high-performance listeners who want mechanism-level clarity on circadian biology, neurodegeneration signals, cognitive training, caffeine strategy, and supplement regulation. Host Dave Asprey connects emerging science, behavioral data, and policy shifts into practical frameworks you can use to build a resilient, adaptable health stack. New episodes every Tuesday, Thursday, Friday, and Sunday. Keywords: David Sinclair age reversal, epigenetic reprogramming therapy, Yamanaka factors OSK, Life Biosciences clinical trial, human rejuvenation trial 2026, biological age reset, longevity breakthrough news, DeepMind Isomorphic Labs, AlphaFold 4 drug design, AI drug discovery engine, geroprotective drug development, peptide gray market risks, injectable glutathathione Tationil Plus, GLP-1 regulation FDA warning, wellness industry regulation, measles outbreak 2026 US, MMR vaccine status adults, vaccine trust public health, health policy 2026 State of the Union, GLP-1 access and reimbursement, telehealth longevity care, biohacking news, anti-aging research update Thank you to our sponsors! Resources: • Get My 2026 Clean Nicotine Roadmap | Enroll for free at https://daveasprey.com/2026-clean-nicotine-roadmap/ • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 0:00 - Introduction 0:30 - Story #1: David Sinclair 2026 2:13 - Story #2: Google Drug Discovery 3:48 - Story #3: El Mencho Biohacking5:30 - Story #4: Measles Outbreak 6:51 - Story #5: Trump State of the Union 8:00 - Weekly Roundup 9:10 - Closing See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Broadcast from KSQD, Santa Cruz on 2-26-2026: Dr. Dawn opens with an urgent measles advisory, noting the virus has an R-value of 15 compared to COVID's peak of 5, with South Carolina reporting over 1,000 cases. She recommends those who received only one MMR shot—particularly people now in their 60s—get an immune titer blood test, as protection declines after 40-50 years. Measles can cause "immune amnesia" destroying immunity to other pathogens, and rarely leads to fatal subacute sclerosing panencephalitis years later. Dr. Dawn criticizes Quest Labs' cholesterol reporting, which flags average levels as "moderate risk" with alarming red H markers even when values fall within their own stated normal ranges. She explains this creates unnecessary panic and pushes patients toward statins based on outdated 2008-2012 guidelines, when cardiology has since recognized that cholesterol can be too low. An emailer asks how an EKG can detect a past heart attack from "jagged lines." Dr. Dawn explains that each spike represents electrical signals moving toward or away from electrode pads, and a 12-lead EKG views the heart from multiple angles—smaller-than-expected spikes in specific leads indicate dead or damaged heart muscle. She urges everyone to learn CPR and AED use, which more than doubles survival chances. An emailer reports that food tastes strong on the first bite but becomes tasteless thereafter. Dr. Dawn identifies numerous medications causing taste changes including calcium channel blockers, beta blockers, statins, diuretics, and even acetaminophen. She also highlights zinc—both deficiency and toxicity above 40mg daily can impair taste, noting a zinc nasal spray was pulled from market after causing smell loss. An emailer asks about Prenuvo full-body MRI scans costing $499-1,000. Dr. Dawn cautions that while Prenuvo found 22 cancers in 1,000 people scanned, 1 in 20 scans requires follow-up biopsy and more than half are false positives—leading to stress, expense, and potential complications from unnecessary procedures. An emailer asks about seed oils after reading a Johns Hopkins article defending them. Dr. Dawn distinguishes fruit oils (olive, avocado) from industrially-extracted seed oils requiring hexane solvent, a neurotoxin that may leave residues despite claims of evaporation. She cites a BMJ study showing coconut oil raised HDL (good cholesterol) while matching olive oil's LDL impact, and recommends cold-pressed oils while avoiding hexane-extracted products, especially for infants.

Dr. Lakshmi Rajdev and Dr. Manish Shah join the podcast to discuss the updated guideline on immunotherapy and targeted therapy in unresectable locally advanced, advanced, or metastatic gastroesophageal cancer. They share first-line and subsequent-line recommendations for both gastroesophageal adenocarcinoma and esophageal squamous cell carcinoma based on actionable biomarkers including PD-L1 expression, MMR and/or MSI, CLDN18.2 expression, and HER2 status. They note the importance of the algorithms and tables in the guidelines that provide visual illustrations and quick reference guides of the evidence-based recommendations. They also comment on ongoing and recently presented trials that may impact future guidelines in this space. Read the full guideline, "Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update" at www.asco.org/gastrointestinal-cancer-guidelines" TRANSCRIPT This guideline, clinical tools and resources are available at www.asco.org/gastrointestinal-cancer-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology,  https://ascopubs.org/doi/10.1200/JCO-25-02958      Timestamps ·       00:00 – 02:15 Introduction and Overview ·       02:16 - 08:20 First-line treatment for patients with pMMR/MSS, HER2-negative gastroesophageal adenocarcinoma ·       08:21 –10:29 First-line treatment for patients with pMMR/MSS, HER2-positive gastroesophageal adenocarcinoma ·       10:30 – 14:39 First-line treatment for patients with dMMR/MSI-H, gastroesophageal adenocarcinoma ·       14:40 – 18:03 First-line treatment for ESCC ·       18:04 – 22:04 Second- and third-line therapy for gastroesophageal adenocarcinoma and ESCC ·       22:05 – 24:38 Importance of guideline ·       24:39 – 27:45 Outstanding questions and future research   Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts.   My name is Brittany Harvey, and today I am interviewing Dr. Lakshmi Rajdev from the Icahn School of Medicine at Mount Sinai and Dr. Manish Shah from Weill Cornell Medicine, co-chairs on "Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update." Thank you for being here today, Dr. Rajdev and Dr. Shah. Dr. Lakshmi Rajdev: Thank you. Dr. Manish Shah: Thank you for having us. It is wonderful. Brittany Harvey: And then just before we discuss this guideline, I would like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Rajdev and Dr. Shah, who have joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. So then to dive into what we are here today to talk about, Dr. Shah, I would like to start first with what prompted the update to this guideline, which was previously published in 2023, and what is the scope of this updated guideline? Dr. Manish Shah: Yes, terrific. So even in the last few years, the pace of drug development in gastroesophageal cancers has just been astounding. So, what prompted this guideline is actually the practice-changing results for a new biomarker, CLDN18.2 hat was based on the GLOW and SPOTLIGHT studies, as well as a practice-changing study in HER2-positive disease where we added pembrolizumab to trastuzumab and chemotherapy for tumors that are HER2-positive and PD-L1 CPS 1 or greater. And then there were also new studies and new approvals in esophageal squamous cell cancer that you will hear about as well. So there were several studies, overall more than 5,000 patients were reported on, and that led to several new therapies, new indications, and it really necessitated this guideline. Brittany Harvey: Excellent. It is great to hear about all of these exciting updates in this space. So then to next review the key recommendations of this guideline by clinical question that the expert panel addressed. So, Dr. Rajdev, what is the recommended first-line treatment for patients with proficient mismatch repair, microsatellite stable, HER2-negative gastroesophageal adenocarcinoma? Dr. Lakshmi Rajdev: Thank you for that question. So historically, we have sort of used fluoropyrimidine and platinum doublets, which yielded a survival of about one year. More recently, immunotherapy and targeted therapy options have improved outcomes in patients with advanced esophageal and gastric adenocarcinoma, as well as squamous cell carcinoma. Patients with gastric and GE junction adenocarcinoma have a high rate of actionable alterations, so it is imperative that physicians test the following biomarkers upfront so that it can help guide therapy. The markers recommended by the ASCO panel are HER2, MMR or MSI, CLDN18.2, and PD-L1. And also, it was recommended to use NGS if feasible in this patient population. HER2, as we know, is expressed in about 15% to 25% of patients; PD-L1 expression occurs in about 80% of patients; MSI-high, deficient MMR is present in about 5% to 8% of patients; and CLDN18.2 expression is present in about 40% of patients. There is, of course, biomarker overlap. About 13% to 22% of CLDN18.2 patients are also PD-L1 positive. For patients with pMMR or microsatellite stable HER2-negative disease with PD-L1 expression greater than 1 and absence of CLDN18.2, the panel recommended a first-line therapy with fluoropyrimidine and platinum-based therapy in combination with immunotherapy. These recommendations stem from large phase 3 trials, and the agents approved in the United States are pembrolizumab, nivolumab, and tislelizumab. It has been shown that immunotherapy benefit is greater in patients with higher PD-L1 expression, and it is not possible to comment on the individual PD-L1 cutoff scores and sort of identify the optimal PD-L1 cutoff score that sort of balances benefits and harms. But what is recommended is that immunotherapy-based treatments can be offered in patients with a CPS score of greater than 1. With regard to the choice of immunotherapy agents, that is pembrolizumab, nivolumab, or tislelizumab, these agents are considered to have similar efficacy, and the selection of an agent could be based on dosing schedule, cost considerations, toxicity, and the method of administration. Typically, clinicians should avoid withholding the start of chemotherapy while awaiting biomarker testing, depending on the clinical scenario. Now, for patients with pMMR microsatellite stable disease that is HER2-negative with PD-L1 expression less than 1 and positive CLDN18.2 expression, zolbetuximab-based treatments or in combination with chemotherapy is recommended, and this is based on two global phase III randomized controlled trials, the GLOW and the SPOTLIGHT. And across both studies, the hazard ratio for the overall survival was 0.78, and similarly, there was also an improvement in progression-free survival favoring the zolbetuximab group compared to the chemotherapy group alone. An important note is that nausea, vomiting is commonly associated with zolbetuximab-based treatments, and the panel recommended prophylactic antiemetics, adjusting zolbetuximab infusion rates, pausing infusion temporarily, using non-prophylactic antiemetics, and hydration intravenously prior to discontinuation of zolbetuximab-based chemotherapy. So effective handling of the GI-related symptoms with zolbetuximab is recommended prior to discontinuation of therapy. Now, for patients with pMMR microsatellite stable HER2-negative gastric, GE junction adenocarcinoma with PD-L1 expression greater than 1 and CLDN18.2 positivity, the ones with the dual expression with CLDN18.2 as well as PD-L1 chemotherapy, the choice of therapy can be based on the degree of PD-L1 expression, the toxicity profile, the burden of symptoms, and the anticipated improvement in symptoms associated with response to treatment, the patient comorbidities, the prior medical and treatment history. So this decision needs to be made on a case-by-case basis, and these are some of the factors that we suggested that could potentially influence the choice of therapy. For patients with pMMR microsatellite stable disease that is HER2-negative and a PD-L1 expression less than 1 and an absence of CLDN18.2 expression, first-line therapy with fluoropyrimidine and platinum-based chemotherapy is recommended. So you can see we have segmented out patients based on PD-L1 expression, pMMR and microsatellite stable disease expression, and also based on CLDN expression. Brittany Harvey: Absolutely. And that first point you noted, I think is really important, that biomarker testing is really critical for treatment decision-making in this space. So then the next subgroup of patients that the panel looked at, Dr. Shah, what first-line therapy is recommended for patients with proficient mismatch repair, microsatellite stable, HER2-positive gastroesophageal adenocarcinoma? Dr. Manish Shah: So this was an update from a few years ago. So we have known for 15 years now that if you are HER2-positive, you should get trastuzumab plus chemotherapy. That was based on the ToGA trial. And the update now is based on a trial called KEYNOTE-811, where it examined the addition of pembrolizumab to trastuzumab and chemotherapy versus trastuzumab and chemotherapy, and there was a progression-free and overall survival benefit. And again, here, the biomarkers are important. If your CPS PD-L1 is less than 1, we would not recommend Pembrolizumab in that setting, so you would still get trastuzumab and chemotherapy. But if it is 1 or greater, the PD-L1 CPS score, then we do recommend pembrolizumab unless there is a contraindication to immunotherapy. The take-home message really is from the onset of diagnosis, please check your biomarkers. And I will just, it is worth repeating, it is important to check your PD-L1 status, HER2 status, mismatch repair status, and CLDN18.2 status. And then the optimal therapy, and it is outlined in the publication, is really biomarker-driven. We know that if we are able to hit the target that is overexpressed, we are going to have a better outcome. And Dr. Rajdev did mention where there is overlap, there can be a lack of data, and that is where we are with both PD-L1 positive and CLDN positive. Here we do have data in HER2-positive cases where if you are both HER2-positive and PD-L1 positive, you would combine trastuzumab and pembrolizumab for the best outcomes. Brittany Harvey: Understood. I really appreciate you detailing what is most important for each individual biomarker combination that patients may have. So then following that, Dr. Rajdev, what does the expert panel recommend for first-line treatment for patients with esophageal squamous cell carcinoma that is not amenable to definitive chemoradiation? Dr. Lakshmi Rajdev: There are three phase III randomized clinical trials that have influenced practice in patients with esophageal squamous cell carcinoma examining the benefit of immunotherapy in this patient population. The RATIONALE-306 was a randomized trial of tislelizumab plus chemotherapy with platinum and fluoropyrimidine or paclitaxel versus placebo with chemotherapy. And then you have the KEYNOTE-590, which compared pembrolizumab plus chemotherapy versus chemotherapy alone. And then you have CheckMate-648, which included comparisons of nivolumab plus chemotherapy versus nivolumab plus ipilimumab or chemotherapy. And the primary endpoints for these studies were overall survival, and they did look at subgroups with PD-L1 expression. They used TPS score greater than 1% in CheckMate-648 and PD-L1 CPS greater than 10 in KEYNOTE-590. The bottom line is that the overall hazard ratio for overall survival across this patient population was 0.72. So clearly, there is benefit in patients that express PD-L1 CPS greater than 1 for benefit for the addition of immunotherapy. Now, the benefit again in patients with a PD-L1 expression less than 1 remains limited, and so the panel has made a recommendation for using immunotherapy in combination with platinum-based chemotherapy in patients with a PD-L1 greater than 1. Again, we know that it is hard to make recommendations on what PD-L1 cutoffs are recommended in this patient population, meaning that should it be limited to patients with a PD-L1 of 1 to 4 or greater than 10? I think that the general consensus that has been gleaned from the data is that the higher the PD-L1 expression, the greater the benefit. I do want to comment on another option that is available in patients with squamous cell carcinoma compared to adenocarcinoma, and that is the combination of nivolumab and ipilimumab. Now, in CheckMate-648, nivolumab with ipilimumab was also recommended as a treatment option in patients that have a PD-L1 score of greater than 1. There was a survival benefit demonstrated with this combination compared to chemotherapy alone. And an important observation in this study is that, although there was a slightly increased rate in early death, but there was really no significant difference in PFS and OS compared to chemotherapy alone. Importantly, the treatment appeared to be pretty well tolerated by the study population. There was a notable difference in the objective response rate, which was 35% in the nivolumab plus ipilimumab group compared to patients receiving nivolumab and chemotherapy, where it was 53%. So superiority is, so the importance of chemotherapy in patients with esophageal squamous cell carcinoma is to be noted. However, there is no difference in overall survival and progression-free survival when using the combination of nivolumab and ipilimumab, and thus it affords a chemotherapy-free option for this patient population with esophageal squamous cell carcinoma and a CPS with a score of greater than 1. Brittany Harvey: Understood. I appreciate you reviewing the evidence underpinning those recommendations as well. So then the next patient population that the guideline panel addressed, what first-line therapy is recommended for patients with deficient mismatch repair, microsatellite instability-high, gastroesophageal adenocarcinoma or esophageal squamous cell carcinoma? Dr. Lakshmi Rajdev: The rate of MSI-high expression is about 3% to 7% across different studies. Now, the KEYNOTE-158 was a tumor-agnostic study in patients with non-colorectal cancers, and again, the problem with the MSI-high population, given that it is so rare, the numbers in the individual studies are fairly small. But consistent outcomes do emerge, indicating high response to immunotherapy. So in KEYNOTE-158, a response rate of about 46% was noted. The number of patients was small, it was about 24. In CheckMate-649, which is a study of chemotherapy plus or minus nivolumab in patients with advanced gastric adenocarcinoma, there was again a very small number of patients, and patients that were MSI-high or deficient MMR did experience substantial benefits with the addition of immunotherapy, with hazard ratios in the order of about 0.38. In KEYNOTE-062, again, it was a very small number of patients, again about 6% or so, and similar to CheckMate-649, a substantial benefit was noted in combination with chemotherapy, but also there were benefits noted with pembrolizumab alone. The RATIONALE-305 again was a study of tislelizumab in combination with chemotherapy and similarly showed benefits to the combination of chemotherapy plus immunotherapy in this patient population. I think that we are all aware of the dramatic benefits of immunotherapy in this particular subset of patients, deficient MMR MSI-high, and also we have seen in CheckMate-649 they did have a subset of patients that received nivolumab and ipilimumab. And in this patient population, they noted unstratified hazard ratio of 0.28. So I think that the overall consensus is that immunotherapy is a very important treatment modality in patients with deficient MMR MSI-high disease, given that a lot of the trials in gastroesophageal adenocarcinoma have utilized chemotherapy-based options, that is certainly a recommendation of the panel to use chemotherapy in combination with immunotherapy. However, on a case-by-case basis, the panel recommended immunotherapy alone as well, and given the high response rates noted in trials across different diseases as well as noted in this disease as well. Brittany Harvey: Certainly. And I appreciate you both for reviewing these first-line recommendations. So moving to later lines of therapy, Dr. Rajdev, what recommendations did the expert panel make for second or third-line therapy for gastroesophageal adenocarcinoma and esophageal squamous cell carcinoma? Dr. Lakshmi Rajdev: So, I think that the RAINBOW trial that investigated the utility of the addition of ramucirumab as second-line therapy has been around since 2014, and those results have led to the addition of ramucirumab to taxane-based therapy in the second-line setting. Based on the utilization of oxaliplatin and platinum-based therapy in the front-line setting, there may be patients that have an underlying neuropathy, and so we wanted to really include treatment options for this patient population so that an agent that is less neurotoxic could also be recommended in combination with ramucirumab. The RAMIRIS trial is one such trial where ramucirumab was combined with FOLFIRI, and it demonstrated benefit in combination with ramucirumab. So we have listed that as a potential treatment option for patients in the second-line setting who may have an underlying neuropathy or even for whatever reason that based on the toxicity profile, that needs to be the preferred option by a physician, that recommendation is new from the older guidelines that we have. With regard to the utility of PD-1 inhibitors, there really has been no benefit noted in the second-line setting with regard to overall survival or progression-free survival, so no recommendation is made for that option. I think an important study that has been recently presented is the DESTINY-Gastric04 trial, which really has been practice-changing and has led to the recommendation for trastuzumab deruxtecan in patients that have HER2-positive metastatic gastric or GE junction adenocarcinoma. Now, this is a phase III trial in patients who retained HER2-positive disease after progressing on front-line trastuzumab-based treatments, and the comparator for this trial was trastuzumab deruxtecan versus ramucirumab plus paclitaxel. There was significant improvement and progression-free survival in patients that received trastuzumab deruxtecan. The patients that were excluded from the trial are patients that have pulmonary problems, interstitial lung disease; that is one of the toxicities of this particular agent, and close monitoring and prompt initiation of therapy such as glucocorticoid treatment in patients who develop this toxicity was also highlighted by the panel. So to summarize, the new guidelines highlight the possibility of FOLFIRI plus ramucirumab as a second-line option and then trastuzumab deruxtecan as a later-line option in patients that still retain HER2 expression. And that is very important because the trial did retest patients whether they expressed HER2. As we know, in a substantial number of patients, there is downregulation of HER2, and there is emerging data that the benefit for subsequent HER2-directed therapies is best noted in patients that still retain HER2 expression. Brittany Harvey: Great. So as our listeners have heard, there are many recommendations and new treatment options for advanced gastroesophageal cancer. Dr. Shah, earlier you highlighted the importance of biomarker testing, but I would like to hear in your view, what is the importance of this guideline and how will it impact both clinicians and patients with gastroesophageal carcinoma? Dr. Manish Shah: So as we have discussed throughout this podcast, the treatment for gastroesophageal cancer, both adenocarcinoma and squamous cell cancer, is increasingly complex, increasingly biomarker-driven. And I think the value of the guideline is to place all of that into context. So it provides the data for why certain biomarkers are important, what therapies should be indicated. Not only that, but if you are able to review the guideline, it provides the details of each of these studies and summarizes them in a meta-analysis fashion to sort of give you the context, because sometimes the individual studies can be maybe a little bit discordant or confusing and the guideline attempts to harmonize all that. And then also, I think the tables are very, very interesting because they give you actual numbers in terms of how many patients over a thousand would this benefit or how many patients over a thousand would this cause harm in terms of nausea, vomiting, or other things like that. So it gives you context for helping clinicians and patients weigh the potential benefits of the novel treatment strategies against the potential adverse events. And then finally, the guideline does also provide an algorithm that you are able to follow based on the biomarkers, and those are in figures 4 and 5. So I think overall, it is a very comprehensive guideline. It intends to make more manageable a very complex subject, and you know, I really encourage our listeners to review it after listening to the podcast. Dr. Lakshmi Rajdev: If I can add to that, I think that what is also really good about the guidelines is there are quick summaries. So if someone is busy in the clinic, of course, there is the opportunity to review the data supporting the guidelines in great depth in the manuscript, but what is also really good is that there are good summaries. In the event that you are very busy, you can easily identify what the recommendations should be for that particular patient based on these summaries. Brittany Harvey: Absolutely. Listeners are encouraged to review the full guideline, including those tables and figures that may be more helpful when they are looking for something quick to look at in the clinic as well. So, as you both mentioned, there have been a number of recent practice-changing trials in this area. So I imagine there is still a lot of ongoing research as well. So Dr. Shah, what are the outstanding questions regarding treatment options for patients with locally advanced unresectable, advanced, or metastatic gastroesophageal carcinoma? Dr. Manish Shah: I think we touched upon it a little bit. The guidelines are based on the data available, and they are primarily examining one novel therapy with chemotherapy in a specific biomarker population. But as you know, the biomarkers are not either/or; you are not either CLDN18.2 positive or PD-L1 positive. A portion of patients could have dual biomarkers, and you know, I think that we are generating data on how to manage those patients. At the recent GI Symposium in January this year, the ILUSTRO trial was presented by Dr. Shitara, which looked at combining zolbetuximab and chemotherapy with immunotherapy for dual-positive biomarkers, and that is leading to a phase III study that has begun to enroll. So unanswered questions are: how do we manage dual-positive biomarkers? The other thing that was mentioned is that the current data for mismatch repair deficiency involve chemotherapy plus immunotherapy. Only squamous cell cancer is there a study with a positive non-chemotherapy kind of backbone, that is CheckMate-648 that Dr. Rajdev mentioned. As we move forward, it will be good to get data on non-chemotherapy options in certain biomarker-positive populations. And then finally, another update, which is likely to be practice-changing, is the HERIZON-GEA-01 study that looked at zanidatamab, which is another biparatopic antibody that targets HER2, and that is likely to change practice. And as that data gets published, we may look to even do a rapid update for the current immunotherapy and targeted therapy guideline that is just being published. Dr. Lakshmi Rajdev: So, if I can add to that, there are numerous ADCs that look very interesting. There are bispecific antibodies; in fact, the zanidatamab is a bispecific antibody showing improved activity in patients with HER2-positive disease. So I think there are studies from Asia looking at CLDN CAR T-based therapies. So, I think that there are a lot of novel agents and a lot of excitement in the field. We know that the bemarituzumab study, unfortunately, the FGFR2 inhibitor failed to demonstrate any benefit, but I think that there are other agents that are being explored, so there are newer targets, newer agents, ADCs, bispecifics that could potentially change the field in the future. Brittany Harvey: Yes, we will look forward to the data to address these unanswered questions and new agents and inform future guideline updates. So, I would like to thank you both for all of your work to review the evidence here and update this important guideline, and for your time today, Dr. Rajdev and Dr. Shah. Dr. Lakshmi Rajdev: Thank you. Dr. Manish Shah: Thank you. Brittany Harvey: And finally, thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/gastrointestinal-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you have heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

In the second part of this 20-Minute Health Talk podcast with Peter Hotez, MD, pediatrician, scientist and global health advocate, the conversation with host Chethan Sathya, MD, shifts to the front lines of health care. Dr. Hotez offers practical advice for clinicians and the public on navigating medical misinformation and myths, such as "turbo cancers.” He also reveals yet another good reason to get your Covid and flu shots — to protect your heart. As he explores the critical public health importance of childhood vaccines like the MMR and Hepatitis B, Dr. Hotez explains the real-world consequences of declining vaccination rates. Finally, he offers his frank assessment of the political and financial forces driving the anti-science movement and how to rebuild public trust. This is Part 2 of this series. Listen to Part 1 About Northwell Health Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch more episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. 

En el año 2000 el sarampión había sido oficialmente erradicado en Estados Unidos, gracias a que un alto porcentaje de la población recibía la denominada vacuna MMR contra la rubeola, las paperas y el sarampión. 26 años más tarde, la situación ha cambiado. En lo que llevamos de año se han registrado más de 900 casos de sarampión en distintos estados y según el Centro para el Control de Enfermedades del país, en dos meses ya llevan un cuarto de todos los casos registrados en 2025. Hablamos con Flor Muñoz, profesora adjunta de pediatría, enfermedades infecciosas y virología molecular y microbiología en la Facultad de Medicina de Baylor y el Hospital Infantil de Texas en Houston.Escuchar audio

Send Zorba a message!Zorba's thoughts on why measles (a virus we had nearly eradicated) is making a comeback, and how you can protect yourself and loved ones.(recorded February 19, 2026)Support the showProduction, edit, and music by Karl Christenson Send your question to Dr. Zorba (he loves to help!): Phone: 608-492-9292 (call anytime) Email: askdoctorzorba@gmail.com Web: www.doctorzorba.org Stay well!

Send Zorba a message!Zorba's thoughts on why measles (a virus we had nearly eradicated) is making a comeback, and how you can protect yourself and loved ones.(recorded February 19, 2026)Support the showProduction, edit, and music by Karl Christenson Send your question to Dr. Zorba (he loves to help!): Phone: 608-492-9292 (call anytime) Email: askdoctorzorba@gmail.com Web: www.doctorzorba.org Stay well!

This week on The Health Advocates, we unpack a series of developments that signal a pivotal moment in U.S. health policy. The FDA has refused to review Moderna’s new mRNA-based flu vaccine, raising questions about regulatory standards and the future of vaccine innovation. At the same time, the Trump administration has launched TrumpRx, a new prescription drug discount platform that promises savings but faces scrutiny over its scope and real-world impact.We also examine new polling showing declining confidence in flu, COVID-19, and MMR vaccines, and the growing legal battle over changes to the federal childhood vaccine schedule. With public trust, regulatory rigor, and patient access all in play, this episode breaks down what these headlines mean for patients — and why clarity and credible science matter more than ever. Contact Our HostSteven Newmark, Chief of Policy at GHLF: snewmark@ghlf.orgA podcast episode produced by Ben Blanc, Director, Digital Production and Engagement at GHLF.We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.orgListen to all episodes of The Health Advocates on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

On this Charlotte Talks, the challenges faced by pediatricians in a world of vaccine resistance. The number of measles cases in South Carolina has risen to 950. It grows almost daily and is entirely preventable if children are given the MMR vaccine for measles, mumps and rubella. Pediatricians are advocating for those vaccines, but some parents are refusing. We look at this phenomenon, its impact on pediatricians, and what's at stake.

What does the future hold for time attack racing in North America?In this Race Industry Week by EPARTRADE interview, Jason Dienhart, President & CEO of Global Time Attack (GTA) and Super Lap Battle (SLB), delivers a candid, in-depth look at where the sport stands today—and where it's headed in 2026.From record-chasing at Buttonwillow to tough economic decisions and a renewed West Coast focus, Dienhart breaks down the realities of running niche motorsport events while protecting the culture that makes time attack special.

In his weekly clinical update, Dr. Griffin and Vincent Racaniello discuss with disgust the decline and fall of American public health and the rise of "only me" when highlighting completion of the US withdrawal from the WHO and possibility of making IPV and MMR optional vaccines, before Dr. Griffin then deep dives into recent statistics RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, Europe losing its measles elimination status, first measles death in Mexico, almost 1000 measles cases in South Carolina, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, the effectiveness of this season's influenza vaccine, where to go for answers to your long COVID questions and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode US completes withdrawal from World Health Organization (AP News) Rejecting Decades of Science, Vaccine Panel Chair Says Polio and Other Shots Should Be Optional (NY Times) A Frightening Interview (Beyond the Noise) Unexplained Pauses in Centers for Disease Control and Prevention Surveillance: Erosion of the Public Evidence Base for Health Policy (Annals of Internal Medicine) Wastewater for measles (WasterWater Scan) UK among 6 European countries losing measles elimination status (Dougall MD: DG Alerts) European Regional Verification Commission for Measles and Rubella Elimination (RVC) (WHO: Europe) Measles Outbreak Associated with an Infectious Traveler — Colorado, May–June 2025 (CDC: MMWR) South Carolina measles cases hit 789, surpassing Texas' 2025 outbreak total (Reuters) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) States across the country report first measles cases of year(CIDRAP) First measles death confirmed in Mexico in 2026 (Mexico News) Influenza: Waste water scan for 11  pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: cliff notes (CDC FluView) Influenza Vaccine Effectiveness Among Children With and Without Underlying Conditions(Pediatrics) OPTION 2: XOFLUZA $50 Cash Pay Option(xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Effectiveness and Durability of the BNT162b2 KP.2 vaccine against COVID-19 Hospitalization and Emergency Department or Urgent Care Encounters in US Adults (OFID) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Association of Nirmatrelvir-ritonavir with intubation or mortality risks in severe COVID-19 patients (BMC Infectious Diseases) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1292 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

The Study Cardiology Willfully Ignored for Over Two Decades Written by Sayer Ji on January 27, 2026. Posted in Current News' https://principia-scientific.com/the-study-cardiology-willfully-ignored-for-over-two-decades/     Authored by Lois Lamerato et al. from Henry Ford Health System study by Lois Lamerato et al  of data from Michigan's integrated healthcare system in Michigan to compare chronic health outcomes in vaccinated versus unvaccinated children. Vaccination exposure was defined as receiving at least one vaccine Vaccinated children had a 2.5 higher adjusted hazard ratio for any chronic condition Specific increcases include asthma, autoimmune disease, atopic disease, eczema, and neurodevelopmental disorders. The 10-year probability of being free from chronic conditions was 83% in unvaccinated vs. 43% in vaccinated. No conditions were higher in unvaccinated.   Study by AR Mawson et al – J Translational Science Survey-based study compared homeschooling children who were vaccinated versus unvaccinated. Higher rates of neurodevelopmental disorders, asthma, and allergies among vaccinated children Vaccinated children had fewer vaccine-preventable infections.   Study by BS Hooker et al – SAGE Open Medicine Retrospective analysis of health outcomes between vaccinated and unvaccinated children. Higher rates of asthma, developmental delays and ear infections in vaccinated children.   Study by NZ Miller – J Translational Science A follow-up analysis to adjust for additional covariates such as breastfeeding and cesarean birth. Reported increased odds of certain chronic conditions among vaccinated children. This is not very convincing study if I am to be honest   Study by AR Mawson & BS Hooker – Frontiers of Public Health Analyzed pediatric billing data and reported increased office visits and diagnoses among vaccinated children. Reported igher rates of neurodevelopmental disorders, asthma, and allergies in vaccinated children However, the journal retracted this article on the grounds it did not disclose conflicts of interest   University of Hong Kong -- This one I know from memory – don't know the journal Double blind placebo study comparing flu vaccinated vesus saline placebo vaccinated Followed for 9 months Vaccinated – almost 4-fold increase in getting other non-flu respiratory infections compared to unvaccinated Only slight increase in flu cases among unvaccinated compared to vaccinated   DeStefano et al -- J Translational Neurdegeneration Study analyzed children in metropolitan Atlanta to examine a link between the age of first MMR vaccine receipt and autism diagnosis. Reports that earlier MMR vaccination increased autism risk in specific subgroups, compared to to later-vaccinated children.   J Lyons-Weiler – Intl J Environmental Research and Public Health Unvaccinated children reportedly had fewer chronic illnesses but more vaccine-preventable infections.   Roma Schmitz et al -  Deutsch Arztebl Intl (German journal) – early study in 2011 Large survey to assess whether vaccination status affects infectious and atopic diseases. Unvaccinated had higher vaccine-preventable diseases (e.g., pertussis, measles) but lower atopic diseases There were fewer median infections in unvaccinated young   P Aaby et al – series of studies between 1995-2016 – BMJ, Vaccine, J Tropical Medicine Some vaccines (especially DTP) associated with higher all cause mortality in low income settings compared to those who did not receive DTP  

John Schoen, Senior Clinical Manager of Evidence-Based Medicine and Drug Information in Vizient's Center for Pharmacy Practice Excellence and Vizient's vaccine subject matter expert, joins host Stacy Lauderdale to discuss key updates to the CDC's childhood Immunization schedule and what they mean for practice.   Guest speaker:     John Schoen, PharmD, BCPS   Senior Clinical Manager of Evidence-Based Medicine and Drug Information    Vizient Center for Pharmacy Practice Excellence     Host:   Stacy Lauderdale, PharmD, BCPS   Associate Vice President  Vizient Center for Pharmacy Practice Excellence   Verified Rx Host    00:00 — Introduction Announcer welcomes listeners to Verified Rx, produced by the Vizient Center for Pharmacy Practice Excellence. 00:14 — Episode Overview Host Stacy Lauderdale introduces the topic: updates to the CDC's U.S. Childhood Immunization Schedule, revised January 20, 2026. Goal of the episode: explain what changed, what didn't, and what it means in practice for providers, pharmacists, and families. Guest: John Schoen, Senior Clinical Manager of Evidence-Based Medicine and Drug Information at Vizient and vaccine subject matter expert. 01:16 — What Changed in the CDC Immunization Schedule CDC reorganized the schedule into three recommendation categories. Vaccines were reclassified, not removed. Number of diseases covered under “routine” recommendations decreased from 17 to 11 due to recategorization. 01:50 — Stated Rationale Behind the Changes Rationale provided in executive summary of scientific assessment. The supporting scientific assessment is available online and referenced for transparency (link in resources below). 03:19 — Were Any Vaccines Removed? No vaccines were removed from the CDC schedule. Some vaccines were shifted into different recommendation categories. 03:40 — Category 1: Routine Childhood Vaccinations Vaccines still routinely recommended for all children include: MMR (measles, mumps, rubella) Polio Tdap / DTaP Hib (Haemophilus influenzae type B) Pneumococcal HPV Varicella (chickenpox) 04:27 — Category 2: Vaccines for High-Risk Populations Vaccines recommended for children who meet specific high-risk criteria: RSV monoclonal antibodies (mAb) Hepatitis A Hepatitis B Quadrivalent meningococcal Meningococcal group B Dengue 05:19 — What Changed vs. Stayed the Same Hepatitis A, Hepatitis B, and quadrivalent meningococcal moved from routine to high-risk RSV mAb recommendations are effectively unchanged, as high-risk infants are defined as those born to mothers who did not receive the maternal RSV vaccine. Dengue remains risk-based. Meningococcal group B remains a mix of risk-based and shared clinical decision-making. 06:31 — Category 3: Shared Clinical Decision Making (SCDM) Defined by ACIP as an individualized decision made jointly by provider and parent/guardian. Allows vaccination when risk-based criteria are not met but benefit is still considered. 06:52 — Vaccines Under SCDM Vaccines now include: Influenza COVID-19 Rotavirus Hepatitis A Hepatitis B Quadrivalent meningococcal Meningococcal group B 08:05 — What's New in SCDM Influenza and rotavirus moved from routine to SCDM. Hepatitis A, hepatitis B, and quadrivalent meningococcal also shifted. COVID-19 moved to SCDM in September 2025 for individuals ≥6 months. 08:28 — Insurance Coverage Implications No expected changes in coverage. Vaccines recommended by CDC as of December 31, 2025 remain: Covered without cost-sharing under Affordable Care Act (ACA) plans. Covered by Medicaid, Children's Health Insurance Program (CHIP), and Vaccines for Children (VFC) program. 09:14 — Impact on Pharmacy Vaccine Access Pharmacists are considered healthcare providers under CDC SCDM definitions. Authority to administer vaccines primarily determined by state laws. Standing orders, protocols, and collaborative practice agreements may need to be updated, as applicable, to address language related to ‘routine' immunizations for children. 10:27 — Recommendations for Providers & Organizations For providers: Become familiar with schedule changes. Be prepared for patient and parent education. Recognize differences between CDC and other professional guidelines. For organizations: Review EHR documentation and order sets. Consult local state regulations to ensure compliance with vaccine administration practices. Review standing orders/protocols and collaborative practice agreements to determine if revisions are needed. Monitor vaccine utilization and adjust inventory accordingly. 11:24 — Resources & Closing Additional CDC and Vizient resources will be linked in the show notes. Announcer closes with subscription and feedback reminder. Links | Resources:    Additional resources HHS press release on changes to childhood immunizations schedule Assessment of US childhood and adolescent immunization schedule HHS fact sheet: CDC childhood immunization schedule Revised CDC child and adolescent immunization schedule ACIP shared clinical decision-making recommendations   Vizient resource Minute Market Insight   VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed  

In this episode, Lindsey sits down with pediatrician Dr. Joel Warsh a.k.a. Dr. Gator, author of Between a Shot and a Hard Place, for the conversation every mom needs to hear. Get an honest look at vaccine safety, parental autonomy, and trusting your intuition in a world of conflicting advice. Ahead, Lindsey + Dr. Gator dive into the chronic illness epidemic—exploring everything from the long-term effects of vaccines to the rise in allergies, autism, and autoimmune conditions in kids today. You'll learn why asking questions isn't “woo-woo”—it's essential to make informed choices.  If you've ever felt judged for going “off schedule” or considered an alternative vaccine approach, this episode brings nuance, compassion, and real data. From toxic ingredients to finding the right doctor, don't miss this must-listen for parents who care about wellness, safety, and sovereignty. We also talk about: The real reasons vaccine schedules have skyrocketed in recent decades What ingredients in vaccines could mean for your child's health Why most doctors won't see families who want alternative vaccine schedules—and what to do about it Debunking the “safe and effective” narrative + what parents actually want to know The myth vs. reality of vaccine injury reporting (VAERS) + what gets missed Pros + cons of delaying or spacing out vaccines—and how to weigh the risks The truth about Hepatitis B at birth, polio, and why some shots might be less urgent than you think Autism, MMR, and the data gaps that you need to hear about Finding “your people” as a parent when conversations around vaccines feel taboo Empowerment tips on trusting your gut, advocating for your child, and demanding better research Resources: Instagram: @drjoelgator X: @drjoelgator Book: www.theshotbook.com Order our book, Almost 30: A Definitive Guide To A Life You Love For The Next Decade and Beyond, here: https://bit.ly/Almost30Book.  Sponsors: Fatty15 | Get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/ALMOST30 and use code ALMOST30 at checkout.  Ka'Chava | Go to kachava.com and use code ALMOST30 for 15% off your next order. Hero Bread | Hero Bread is offering 10% off your order. Go to hero.co and use code ALMOST30 at checkout. Revolve | Shop at REVOLVE.com/ALMOST30 and use code ALMOST30 for 15% off your first order. #REVOLVEpartner BetterHelp | This episode is brought to you by BetterHelp. Give online therapy a try at betterhelp.com/almost30 and get on your way to being your best self with 10% off your first month. Chime | It just takes a few minutes to sign up. Head to Chime.com/ALMOST30. Paleovalley | Head to paleovalley.com/almost30 for 15% off your order! Our Place | Visit fromourplace.com/ALMOST30 and use code ALMOST30 for 10% off sitewide.  To advertise on this podcast please email: partnerships@almost30.com. Learn More: https://almost30.com/about https://almost30.com/morningmicrodose https://almost30.com/book Join our community: https://facebook.com/Almost30podcast/groups https://instagram.com/almost30podcast https://tiktok.com/@almost30podcast https://youtube.com/Almost30Podcast Podcast disclaimer can be found by visiting: almost30.com/disclaimer.  Almost 30 is edited by Garett Symes and Isabella Vaccaro. Learn more about your ad choices. Visit megaphone.fm/adchoices

Automatic Script Execution In Visual Studio Code Visual Studio Code will read configuration files within the source code that may lead to code execution. https://isc.sans.edu/diary/Automatic%20Script%20Execution%20In%20Visual%20Studio%20Code/32644 Cisco Unified Communications Products Remote Code Execution Vulnerability A vulnerability in Cisco Unified Communications Manager (Unified CM), Cisco Unified Communications Manager Session Management Edition (Unified CM SME), Cisco Unified Communications Manager IM & Presence Service (Unified CM IM&P), Cisco Unity Connection, and Cisco Webex Calling Dedicated Instance could allow an unauthenticated, remote attacker to execute arbitrary commands on the underlying operating system of an affected device. https://sec.cloudapps.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-voice-rce-mORhqY4b Zoom Vulnerability A Command Injection vulnerability in Zoom Node Multimedia Routers (MMRs) before version 5.2.1716.0 may allow a meeting participant to execute remote code on the MMR via network access. https://www.zoom.com/en/trust/security-bulletin/zsb-26001/ Possible new SSO Exploit (CVE-2025-59718) on 7.4.9 https://www.reddit.com/r/fortinet/comments/1qibdcb/possible_new_sso_exploit_cve202559718_on_749/ SANS SOC Survey The 2026 SOC Survey is open, and we need your input to create a meaningful report. Please share your experience so we can advocate for what actually works in the trenches. https://survey.sans.org/jfe/form/SV_3ViqWZgWnfQAzkO?is=socsurveystormcenter

A large U.S. cohort study found that children who were late for routine 2- or 4-month immunizations were six to seven times more likely to miss MMR vaccination entirely by age two, highlighting early delays as a strong predictor of future vaccine refusal amid rising measles cases. A long-term study of more than 27,000 women showed that very high lipoprotein(a) levels were associated with substantially increased cardiovascular risk over 30 years, supporting targeted one-time screening. Finally, Medicare data revealed that one in four older adults with dementia received CNS-active medications, often without clear indications, underscoring opportunities to reduce inappropriate prescribing.

Kyle welcomes Dr. Andrew Wakefield, a controversial figure known for his claims linking the MMR vaccine to autism. Wakefield shares his journey from a traditional medical background to becoming a prominent critic of vaccines. The podcast covers the initial study published in The Lancet, its subsequent backlash, and Wakefield's journey through public and professional challenges. Wakefield discusses his transition to filmmaking as a means to spread his message, highlighting his documentary 'Vaxxed' and other key works. The conversation delves into the impact of vaccines on public health, the introduction and potential risks of mRNA vaccines, and broader issues surrounding vaccine policies and public trust. Highlighted are the testimonies of parents with vaccine-injured children, the legal and scientific battles against the mainstream medical community, and the importance of public awareness. The podcast also explores alternative treatments for vaccine-related injuries, emphasizing gut health and the potential benefits of cannabinoids. Dr. Wakefield expresses hope for more informed public health policies and discusses his plans for future projects, including a film addressing the long-term impacts on children left behind by vaccination policies.   Connect with Andy here: Website - Wakefield Media Group Instagram   From Kyle: The Community is coming! Click here to learn more Full Temple Reset is back with Erick Godsey, Click here to learn more   Our Sponsors: Let's level up your nicotine routine with Lucy. Go to Lucy.co/KKP and use promo code (KKP) to get 20% off your first order. Lucy offers FREE SHIPPING and has a 30-day refund policy if you change your mind. These are the b3 bands I was talking about. They are amazing, I highly recommend incorporating them into your movement practice. Go to tonum.com/KKP, use the code KKP, and get 10% off your first order of Nouro.   Connect with Kyle: I'm back on Instagram, come say hey @kylekingsbu Twitter: @kingsbu Our Farm Initiative: @gardenersofeden.earth Odysee: odysee.com/@KyleKingsburypod Youtube: https://www.youtube.com/@Kyle-Kingsbury Kyle's Website: www.kingsbu.com - Gardeners of Eden site If you enjoyed this podcast, please subscribe & leave a 5-star review with your thoughts!

Under Health Secretary RFK Jr's guidance, the CDC has made changes to recommendations for the childhood vaccine schedule. Jessica Malaty Rivera, infectious disease epidemiologist and member of the group Defend Public Health, explains what the changes are and why they are such a big deal for public health.

In "Flu Takes Charge" Dr. Osterholm and Chris Dall give us an update on the emerging flu season, Dr. Osterholm covers a new poll that shows fewer Americans are willing to recommend the MMR vaccine, and we'll hear about the Vaccine Integrity Project's latest video.Resources for vaccine and public health advocacy: Voices for Vaccines Families Fighting Flu Vaccinate Your Family Shot@Life Medical Reserve Corps Learn more about the Vaccine Integrity Project MORE EPISODES       SUPPORT THIS PODCAST

How Conventional Medicine Is Ruining Our Kids | Dr. Larry PalevskyTurn online alignment into an offline community — join us at TheWayFwrd.com to connect with like-minded people near you.We're watching an entire generation of children get sicker, and the medical system still won't admit it's out of answers. Parents see it. Practitioners see it. And the gap between real-world patterns and the official explanations around childhood illness keeps widening.In this episode, Dr. Larry Palevsky breaks down the observations that pushed him to question the pediatric model from within. Standard protocols weren't helping. Some interventions were making symptoms worse. And the infection-based framework he was trained to follow simply didn't explain the chronic inflammation, neurodevelopmental issues, or immune dysregulation showing up in real kids.Looking for clarity, he stepped outside the conventional lane—into nutrition, Chinese medicine, chiropractic, reiki, herbology, and other holistic approaches that offered a fuller picture of children's health. That search opened deeper questions about vaccine ingredients, aluminum adjuvants, immune overload, environmental toxicity, and whether our definition of “infection” actually matches what's happening inside children's bodies.This conversation is for anyone who already knows the system is breaking kids—and wants the language, context, and coherence to understand why, and what truly supports long-term health.You'll Learn:[00:00:00] Introduction[00:06:23] The lost art of Clinical Medicine[00:07:38] The emergency room revelation about ear infections and antibiotics[00:12:21] Discovering the concept of "the body has the innate capacity to heal"[00:17:09] Using reiki in the delivery room to save babies[00:23:24] The pivotal moment a mother asked about mercury in vaccines[00:26:42] The premature baby saved by fish oil[00:33:14] Why Dr. Larry stopped vaccinating and started educating[00:42:18] The troubling science of aluminum adjuvants in vaccines[01:03:08] Three brain regions where nanoparticles travel[01:06:29] What sorbitol in MMR might actually be doing[01:18:21] Why vaccines are "safe and effective" is the wrong debate[01:24:10] The real contagion theory no one talks about[01:34:07] Acute illness is rarely an infection[01:48:42] The 15-year-old diagnosed with autism who actually had addiction[01:41:59] The autism debate, diagnostic labels, and the dozen causes of brain injury in children[02:04:26] The parenting advice that sounds cruel but builds resilience[02:08:40] What "making children well again" actually requires [02:22:15] Symptoms are just the body doing its job[02:16:53] The two-part vision: reforming pediatrics and reclaiming allopathic medicineResources Mentioned:Danish Study on 1.2 Million Children Settles the Vaccine-Autism Debate | ArticleCan You Catch A Cold? By Daniel Roytas | BookFind more from Dr. Larry Palevsky:Dr. Palevsky | WebsiteDr. Palevsky | InstagramFind more from Alec:Alec Zeck | InstagramAlec Zeck | XThe Way Forward | InstagramThe Way Forward is Sponsored By:Designed for deep focus and well-being. 100% blue light and flicker free. For $50 off your Daylight Computer, use discount code: TWF50New Biology Clinic: Redefine Health from the Ground UpExperience tailored terrain-based health services with consults, livestreams, movement classes, and more. Visit www.NewBiologyClinic.com and use code TheWayForward for $50 off activation. Members get the $150 fee waived

Setting: President Trump held a press conference after attending Charlie Kirk’s funeral, teasing it as a “major announcement” on autism and public health. Main Claim: Trump and RFK Jr. asserted that acetaminophen (Tylenol) use during pregnancy may be associated with an increased risk of autism in children. Trump directly warned against taking Tylenol while pregnant, except in extreme cases of high fever. Autism Statistics (as presented by Trump): Historical rates cited: 1 in 20,000 → 1 in 10,000 → 1 in 31 overall today, and as high as 1 in 12 among boys in some regions (e.g., California). He described this increase as “artificial” and linked it to medication and vaccines. Specific Policy Steps Announced: FDA to issue warnings and update labeling for acetaminophen, cautioning its use during pregnancy. NIH, FDA, CDC, and CMS to coordinate a new effort investigating potential environmental, pharmaceutical, and vaccine links to autism. New grant funding (13 awards) through NIH’s Autism Data Science Initiatives. Other Health Proposals Trump Raised: Vaccines: suggested spacing them out, avoiding certain ingredients (mercury, aluminum), giving MMR separately, and delaying hepatitis B vaccination until age 12. Treatment: referenced new findings suggesting folate deficiency in children may contribute to autism, with therapies under research. RFK Jr.’s Role: He emphasized that past autism research was too focused on genetics and ignored environmental/toxic exposures. Supported Trump’s push to investigate acetaminophen, vaccines, and other potential causes. Announced NIH/FDA would pursue depoliticized research, new label warnings, and public education campaigns. Please Hit Subscribe to this podcast Right Now. Also Please Subscribe to the The Ben Ferguson Show Podcast and Verdict with Ted Cruz Wherever You get You're Podcasts. And don't forget to follow the show on Social Media so you never miss a moment! Thanks for Listening X: https://x.com/benfergusonshowYouTube: https://www.youtube.com/@VerdictwithTedCruzSee omnystudio.com/listener for privacy information.